This stock will be big - the founder, Paul Hopper, is an expert in this area, he sold his Viralytics business to Merck for $400m + in 2018, he is currently involved with Imugene who have massive potential and his network and expertise in the area of Oncology and cancer therapeutics is extensive - they're early at the moment but this has HUGE upside potential and is a stock i will definitely be lumping in and forgetting about for the next couple of years as they develop the technology
This stock will be big - the founder, Paul Hopper, is an expert...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4817793 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18563373 | 21 |
View Market Depth
| Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |